$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals
09:31am, Monday, 22'nd Dec 2025
Amgen and eight other pharma giants struck deals with the Trump administration to cut U.S. drug prices while gaining tariff relief and manufacturing incentives.
Perpetual Ltd Takes Position in Amgen Inc. $AMGN
05:40am, Monday, 22'nd Dec 2025
Perpetual Ltd bought a new stake in Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,907 shares of
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of “Moderate Buy” from Analysts
01:32am, Monday, 22'nd Dec 2025
Amgen Inc. (NASDAQ: AMGN - Get Free Report) has been given an average rating of "Moderate Buy" by the twenty-two ratings firms that are presently covering the company, Marketbeat reports. One research
Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA
05:06am, Sunday, 21'st Dec 2025
CHICAGO TRUST Co NA decreased its stake in Amgen Inc. (NASDAQ: AMGN) by 60.5% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fi
Dividend ETF Matchup: SCHD Offers Higher Yield While VIG Leads in Growth
07:09pm, Saturday, 20'th Dec 2025
Yield, sector focus, and risk profiles set these two dividend ETFs apart-see how their distinct strategies may fit different investor goals.
Bartlett & CO. Wealth Management LLC Reduces Stock Position in Amgen Inc. $AMGN
03:33am, Saturday, 20'th Dec 2025
Bartlett and CO. Wealth Management LLC cut its holdings in Amgen Inc. (NASDAQ: AMGN) by 2.1% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchan
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
01:38am, Saturday, 20'th Dec 2025
Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.
This year's biotech laggards primed for 2026 recovery, says Goldman Sachs' Richter
06:25pm, Friday, 19'th Dec 2025
CNBC's “Closing Bell Overtime” team discusses why the biotech recovery may continue into 2026 with Salveen Richter, lead U.S. biotech analyst at Goldman Sachs Research.
Market Today: Oracle-TikTok JV, Tesla Pay Reinstated, Nike Sinks
05:35pm, Friday, 19'th Dec 2025
Guru Stock PicksVanguard Health Care Fund has made the following transactions:Reduce in ARGX by 14.38%Sold out in PACSAdd in CLDX by 3.64%New position in PTGXCI
Trump strikes deal with US drugmakers to cut Medicaid medicine costs
03:14pm, Friday, 19'th Dec 2025
Officials pledge ‘massive savings' as companies agree to offer drugs at prices paid in other wealthy countries
Nine of the largest pharma companies ink deals with Trump to lower drug prices
02:34pm, Friday, 19'th Dec 2025
Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation's drug
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
02:23pm, Friday, 19'th Dec 2025
Underscores Long-Standing Commitment to Investing in Innovation and U.S. Manufacturing THOUSAND OAKS, Calif. , Dec. 19, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced it is taking action aga
Trump to announce new drug-pricing deals later today
10:45am, Friday, 19'th Dec 2025
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.
Dynavax Technologies (NASDAQ:DVAX) vs. Amgen (NASDAQ:AMGN) Head to Head Survey
01:42am, Friday, 19'th Dec 2025
Amgen (NASDAQ: AMGN - Get Free Report) and Dynavax Technologies (NASDAQ: DVAX - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based o
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
10:01am, Wednesday, 17'th Dec 2025
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Sign In
Buy AMGN